In the midst of a reorganization, Beckman Coulter this week reported that its third-quarter sales grew by 2 percent, beating management's earlier forecasts for the quarter.

While a change in leasing policy for its instruments resulted in lower quarterly sales than Beckman would have recognized under its older policy, President and CEO Scott Garrett reiterated the company's belief that this and other restructuring initiatives would start to pay off next year.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.